On May 11th, 2023 Dr Brad Estes, CytexOrtho Co-founder and CEO, traveled to Washington D.C. to sit on a panel about the state of osteoarthritis (OA) in the United States, and the need for additional funding to move scientific advances combating OA to the clinic. The event was hosted by the Arthritis Foundation in collaboration with the newly formed nonprofit, [email protected]
Dr Estes gave a presentation highlighting the ongoing work here at CytexOrtho moving our Breakthrough Device cartilage regeneration implants to clinical trials. He spoke with members of congress, the press, and representatives from the Arthritis Foundation about our technology and our path to the clinic.
The event drew interest from the press, resulting in publications on multiple platforms, including Business Wire and MeriTalk (see links below).
The event was recorded, and you can watch it on the [email protected] website: https://www.angryarthritis.org/oa-innovation-shark-tank/
Business Wire: https://www.businesswire.com/news/home/20230512005358/en/Global-Osteoarthritis-Leaders-Host-OA-Innovation-Shark-Tank-Meeting-at-U.S.-Congress-to-Showcase-Promise-of-New-Cures-%E2%80%93-Call-for-Increased-Federal-Funding-and-Transparency